rac-beta serine/threonine kinase (AKT2 kinase, protein kinase B-beta, PKB beta, AKT2)
Jump to navigation
Jump to search
Function
- general protein kinase capable of phosphorylating several known proteins
- 2 specific sites, one in the kinase domain (Thr-309) & the other in the C-terminal regulatory region (Ser-474), need to be phosphorylated for its full activation
Structure
- belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family, RAC subfamily
- contains 1 AGC-kinase C-terminal domain
- contains 1 PH domain
- contains 1 protein kinase domain
Expression
- expressed in all human cell types so far analyzed
- highly expressed in insulin responsive tissues
Pathology
- alterations of AKT2 may contribute to the pathogenesis of ovarian carcinomas
- mutation associated with severe insulin resistance & diabetes mellitus in one family[2]
More general terms
References
- ↑ UniProt http://www.uniprot.org/uniprot/P31751.html
- ↑ 2.0 2.1 George S, Rochford JJ, Wolfrum C, Gray SL, Schinner S et al A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science. 2004 May 28;304(5675):1325-8. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15166380
- ↑ Atlas of genetics & cytogenetics in oncology & haematology http://atlasgeneticsoncology.org/genes/AKT2ID517ch19q13.html